242 related articles for article (PubMed ID: 31085212)
1. β-Sitosterol from Ifloga spicata (Forssk.) Sch. Bip. as potential anti-leishmanial agent against leishmania tropica: Docking and molecular insights.
Majid Shah S; Ullah F; Ayaz M; Sadiq A; Hussain S; Ali Shah AU; Adnan Ali Shah S; Wadood A; Nadhman A
Steroids; 2019 Aug; 148():56-62. PubMed ID: 31085212
[TBL] [Abstract][Full Text] [Related]
2.
Güler E; Özbilgin A; Çavuş İ; Baddal B; Etikan İ; Başer KHC; Şanlıdağ T
Turkiye Parazitol Derg; 2021 Jun; 45(2):101-107. PubMed ID: 34103285
[TBL] [Abstract][Full Text] [Related]
3. In-vitro biological evaluation of 3,3',5,5'-tetramethoxy-biphenyl-4,4'-diol and molecular docking studies on trypanothione reductase and Gp63 from Leishmania amazonensis demonstrated anti-leishmania potential.
Schirmann JG; Bortoleti BTS; Gonçalves MD; Tomiotto-Pellissier F; Camargo PG; Miranda-Sapla MM; Lima CHS; Bispo MLF; Costa IN; Conchon-Costa I; Pavanelli WR; Dekker RFH; Barbosa-Dekker AM
Sci Rep; 2023 Apr; 13(1):6928. PubMed ID: 37117253
[TBL] [Abstract][Full Text] [Related]
4. Bioassay-based Corchorus capsularis L. leaf-derived β-sitosterol exerts antileishmanial effects against Leishmania donovani by targeting trypanothione reductase.
Pramanik PK; Chakraborti S; Bagchi A; Chakraborti T
Sci Rep; 2020 Nov; 10(1):20440. PubMed ID: 33235245
[TBL] [Abstract][Full Text] [Related]
5. Antileishmanial, DNA Interaction, and Docking Studies of Some Ferrocene-Based Heteroleptic Pentavalent Antimonials.
Rauf MK; Shaheen U; Asghar F; Badshah A; Nadhman A; Azam S; Ali MI; Shahnaz G; Yasinzai M
Arch Pharm (Weinheim); 2016 Jan; 349(1):50-62. PubMed ID: 26627058
[TBL] [Abstract][Full Text] [Related]
6. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
[TBL] [Abstract][Full Text] [Related]
7. In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Jamal Q; Khan NH; Wahid S; Awan MM; Sutherland C; Shah A
Exp Parasitol; 2015 Jul; 154():93-7. PubMed ID: 25911243
[TBL] [Abstract][Full Text] [Related]
8. In vitro anti-leishmanial activity of Prunus armeniaca fractions on Leishmania tropica and molecular docking studies.
Shaheen N; Qureshi NA; Ashraf A; Hamid A; Iqbal A; Fatima H
J Photochem Photobiol B; 2020 Dec; 213():112077. PubMed ID: 33220600
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antileishmanial activity of novel pyridinium-hydrazone derivatives.
Alptuzun V; Cakiroglu G; Limoncu ME; Erac B; Hosgor-Limoncu M; Erciyas E
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):960-7. PubMed ID: 22803671
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of New Cyclic Imides Derived from Safrole, Structure- and Ligand-based Approaches to Evaluate Potential New Multitarget Agents Against Species of Leishmania.
de Sousa Luis JA; da Silva Costa NA; Luis CCS; Lira BF; Athayde-Filho PF; de Souza Lima TK; da Câmara Rocha J; Scotti L; Scotti MT
Med Chem; 2020; 16(1):39-51. PubMed ID: 31208311
[TBL] [Abstract][Full Text] [Related]
11. Leishmanicidal and cytotoxic activities of Nigella sativa and its active principle, thymoquinone.
Mahmoudvand H; Tavakoli R; Sharififar F; Minaie K; Ezatpour B; Jahanbakhsh S; Sharifi I
Pharm Biol; 2015 Jul; 53(7):1052-7. PubMed ID: 25471014
[TBL] [Abstract][Full Text] [Related]
12. Molecular Docking, Antioxidant, Anticancer and Antileishmanial Effects of Newly Synthesized Quinoline Derivatives.
Malghani Z; Khan AU; Faheem M; Danish MZ; Nadeem H; Ansari SF; Maqbool M
Anticancer Agents Med Chem; 2020; 20(13):1516-1529. PubMed ID: 32416701
[TBL] [Abstract][Full Text] [Related]
13. Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship.
Fan Y; Lu Y; Chen X; Tekwani B; Li XC; Shen Y
Molecules; 2018 Nov; 23(11):. PubMed ID: 30400596
[TBL] [Abstract][Full Text] [Related]
14. Natural products derived steroids as potential anti-leishmanial agents; disease prevalence, underlying mechanisms and future perspectives.
Elawad MA; Elkhalifa MEM; Hamdoon AAE; Salim LHM; Ahmad Z; Ayaz M
Steroids; 2023 May; 193():109196. PubMed ID: 36764565
[TBL] [Abstract][Full Text] [Related]
15. Cocrystals of a coumarin derivative: an efficient approach towards anti-leishmanial cocrystals against MIL-resistant Leishmania tropica.
Shahbaz M; Farooq S; Choudhary MI; Yousuf S
IUCrJ; 2024 Mar; 11(Pt 2):224-236. PubMed ID: 38427455
[TBL] [Abstract][Full Text] [Related]
16. Biosynthesis of anti-leishmanial natural products in callus cultures of Artemisia scoparia.
Yousaf R; Khan MA; Ullah N; Khan I; Hayat O; Shehzad MA; Khan I; Taj F; Ud Din N; Khan A; Naeem I; Ali H
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1122-1131. PubMed ID: 30942629
[TBL] [Abstract][Full Text] [Related]
17. Effect of the anti-microtubule compound tubulozole on Leishmania protozoan parasites in vitro.
Fong D
FEMS Microbiol Lett; 1993 Feb; 107(1):95-9. PubMed ID: 8468004
[TBL] [Abstract][Full Text] [Related]
18. Novel coumarin-isatin hybrids as potent antileishmanial agents: Synthesis, in silico and in vitro evaluations.
Khatoon S; Aroosh A; Islam A; Kalsoom S; Ahmad F; Hameed S; Abbasi SW; Yasinzai M; Naseer MM
Bioorg Chem; 2021 May; 110():104816. PubMed ID: 33799180
[TBL] [Abstract][Full Text] [Related]
19. Oxazolo[3,2-a]pyridine. A new structural scaffold for the reversal of multi-drug resistance in Leishmania.
Caballero E; Manzano JI; Puebla P; Castanys S; Gamarro F; San Feliciano A
Bioorg Med Chem Lett; 2012 Oct; 22(19):6272-5. PubMed ID: 22939695
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of Anti-leishmanial Effects of Bee Products (Honey, Propolis) on Leishmania tropica Promastigotes].
Aksoy T; Sivcan E; Doğan F; Çetin S; Yar TM
Mikrobiyol Bul; 2020 Jul; 54(3):479-489. PubMed ID: 32755522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
